ESR1 and breast cancer: Based on an immunohistochemical (IHC) expression panel of estrogen receptors (ER), progesterone receptors (PR), HER2 and Ki67, BC have been classified in four surrogate subtypes: triple negative, HER2-positive and two types of luminal, the latter being the most frequent.